Browse > Home / Uncategorized / Europe’s CHMP Supports Approval of Five Generic Products

Europe’s CHMP Supports Approval of Five Generic Products

August 12, 2009

Europe’s CHMP Supports Approval of Five Generic Products
The European Medicines Agency’session Committee for Medicinal Products in quest of Human Use (CHMP) has recommended granting marketing authorizations for several generic products. Generic-drug maker Krka received sure opinions for its Enyglid (repaglinide) and Repaglinide Krka, what one. are versions of Novo Nordisk’s Type 2 diabetes treatment NovoNorm. Teva Pharmaceuticals Europe has believed a positive opinion for its generic versions of NovoNorm, Sanofi-Aventis’ hypertension remedy Aprovel and GlaxoSmithKline’s Zeffix, which is used to treat chronic hepatitis B. CHMP in like manner recommended approval of Mylan’s clopidogrel besylate, which would compete with Plavix.

Written by Samanta · Filed Under Uncategorized